S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NASDAQ:NYXH

Nyxoah (NYXH) Stock Price, News & Analysis

$13.49
+0.23 (+1.73%)
(As of 03/28/2024 ET)
Today's Range
$13.16
$13.67
50-Day Range
$4.41
$19.50
52-Week Range
$4.00
$20.00
Volume
12,713 shs
Average Volume
65,799 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$20.60

Nyxoah MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.83 Rating Score
Upside/​Downside
52.7% Upside
$20.60 Price Target
Short Interest
Bearish
3.14% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.42mentions of Nyxoah in the last 14 days
Based on 8 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.24 out of 5 stars

NYXH stock logo

About Nyxoah Stock (NASDAQ:NYXH)

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

NYXH Stock Price History

NYXH Stock News Headlines

Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
Nyxoah (NASDAQ:NYXH) Given Buy Rating at HC Wainwright
Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
Nyxoah S.A. (NYXH) Q4 2023 Earnings Call Transcript
Preview: Nyxoah's Earnings
Nyxoah SA Ordinary Shares NYXH
Nyxoah Announces 2024 Strategic Priorities
See More Headlines
Receive NYXH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nyxoah and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/05/2024
Today
3/29/2024
Next Earnings (Estimated)
5/21/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:NYXH
Employees
137
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$20.60
High Stock Price Target
$27.00
Low Stock Price Target
$14.00
Potential Upside/Downside
+52.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.83
Research Coverage
6 Analysts

Profitability

Net Income
$-46,770,000.00
Net Margins
-993.28%
Pretax Margin
-1,027.03%

Debt

Sales & Book Value

Annual Sales
$4.70 million
Book Value
$5.08 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
1.51
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Robert Taub MBA (Age 77)
    Co-Founder & Chairman
    Comp: $84.24k
  • Mr. Olivier Taelman (Age 52)
    CEO & Executive Director
    Comp: $689.68k
  • Mr. Loic Moreau (Age 44)
    Chief Financial Officer
    Comp: $346.42k
  • Mr. Bruno Onkelinx
    Chief Technology Officer
  • Mikaela Kirkwood
    Corporate Communication & Investor Relations Manager
  • Ms. An Moonen
    General Counsel
  • Mr. Remi Renard
    Vice President of Market & Market Access
  • Ms. Inge Vanwittenbergh
    Global Human Resource Director
  • Mr. David M. DeMartino
    Chief Strategy Officer
  • Mr. Jeyakumar Subbaroyan
    Chief Clinical Officer

NYXH Stock Analysis - Frequently Asked Questions

Should I buy or sell Nyxoah stock right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nyxoah in the last year. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" NYXH shares.
View NYXH analyst ratings
or view top-rated stocks.

What is Nyxoah's stock price target for 2024?

6 equities research analysts have issued 1 year target prices for Nyxoah's shares. Their NYXH share price targets range from $14.00 to $27.00. On average, they anticipate the company's stock price to reach $20.60 in the next year. This suggests a possible upside of 52.7% from the stock's current price.
View analysts price targets for NYXH
or view top-rated stocks among Wall Street analysts.

How have NYXH shares performed in 2024?

Nyxoah's stock was trading at $4.64 at the start of the year. Since then, NYXH stock has increased by 190.7% and is now trading at $13.49.
View the best growth stocks for 2024 here
.

Are investors shorting Nyxoah?

Nyxoah saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 290,900 shares, an increase of 65.6% from the February 29th total of 175,700 shares. Based on an average daily volume of 59,200 shares, the days-to-cover ratio is currently 4.9 days. Approximately 3.1% of the company's shares are sold short.
View Nyxoah's Short Interest
.

When is Nyxoah's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 21st 2024.
View our NYXH earnings forecast
.

How were Nyxoah's earnings last quarter?

Nyxoah S.A. (NASDAQ:NYXH) posted its earnings results on Tuesday, March, 5th. The company reported ($0.41) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.41). The firm earned $1.96 million during the quarter, compared to analyst estimates of $2.01 million. Nyxoah had a negative net margin of 993.28% and a negative trailing twelve-month return on equity of 38.58%.

What guidance has Nyxoah issued on next quarter's earnings?

Nyxoah updated its fourth quarter 2023 earnings guidance on Tuesday, January, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $2.0 million-$2.0 million, compared to the consensus revenue estimate of $1.5 million.

When did Nyxoah IPO?

Nyxoah (NYXH) raised $83 million in an initial public offering (IPO) on Friday, July 2nd 2021. The company issued 2,760,000 shares at $30.00 per share.

Who are Nyxoah's major shareholders?

Nyxoah's stock is owned by many different retail and institutional investors. Top institutional shareholders include Opaleye Management Inc. (1.38%), Goldman Sachs Group Inc. (0.00%) and Goldman Sachs Group Inc. (0.00%).

How do I buy shares of Nyxoah?

Shares of NYXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NYXH) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners